Emerging Technology

Predictmedix cites growing role in health and safety for its device’s success

The company also expects to submit its application for 510(k) clearance for its OneRF Trigeminal Nerve Ablation System in May, sooner than expected.

Under the terms, Boston Scientific will pay about $443 million upfront, plus up to $221 million if regulatory milestones occur.

Omid Veiseh, PhD, faculty director of the Rice Biotech Launchpad, discusses his organization’s mission to create innovative biotechnology based on patient need.

FDA approves Dawes-Redman CTG analysis for U.S. use, enhancing fetal monitoring

Triage solution is built on existing AI engine

Autonomous solution doesn’t require dilation in vast majority of cases

A market analysis report from Grand View Research projects the AI diagnostics market size to grow at a CAGR of 24.60% through 2030.